Horizon Kinetics Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.13M | Sell |
|
|||||
|
2025
Q2 | $900K | Sell |
|
|||||
|
2025
Q1 | $778K | Hold |
|
|||||
|
2024
Q4 | $678K | Buy |
|
|||||
|
2024
Q3 | $759K | Sell |
|
|||||
|
2024
Q2 | $700K | Hold |
|
|||||
|
2024
Q1 | $430K | Hold |
|
|||||
|
2023
Q4 | $551K | Sell |
|
|||||
|
2023
Q3 | $531K | Hold |
|
|||||
|
2023
Q2 | $570K | Hold |
|
|||||
|
2023
Q1 | $601K | Hold |
|
|||||
|
2022
Q4 | $713K | Hold |
|
|||||
|
2022
Q3 | $600K | Hold |
|
|||||
|
2022
Q2 | $438K | Hold |
|
|||||
|
2022
Q1 | $490K | Hold |
|
|||||
|
2021
Q4 | $509K | Hold |
|
|||||
|
2021
Q3 | $566K | Hold |
|
|||||
|
2021
Q2 | $509K | Hold |
|
|||||
|
2021
Q1 | $424K | Hold |
|
|||||
|
2020
Q4 | $390K | Hold |
|
|||||
|
2020
Q3 | $437K | Hold |
|
|||||
|
2020
Q2 | $444K | Buy |
|